• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国成人血液科患者队列中侵袭性真菌病诊断和治疗成本的前瞻性评估。

Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK.

机构信息

Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK

Aquarius Population Health, Bristol, UK.

出版信息

J Antimicrob Chemother. 2015 Apr;70(4):1175-81. doi: 10.1093/jac/dku506. Epub 2014 Dec 21.

DOI:10.1093/jac/dku506
PMID:25535218
Abstract

OBJECTIVES

The direct cost of invasive fungal disease (IFD) includes antifungal drugs as well as diagnostic tests. The aim of this study was to determine these costs.

METHODS

A total of 203 haematology patients were enrolled into the study and followed for a median of 556 days. Data were prospectively collected on antifungal drugs, diagnostic tests, length of stay and antibiotic usage.

RESULTS

The overall mean (IQR) cost of care per patient (using UK-based reference costs) was £88 911 (45 339-121 594), £61 509 (39 748-78 383), £50 332 (23 037-72 057) and £34 075 (19 928-43 900) for proven/probable IFD, possible IFD, not classified and no evidence of IFD, respectively (P<0.001). The attributable cost of IFD was £54 836. Inpatient hospital stay accounted for nearly 74% of costs. In proven/probable IFD inpatient care, antifungals, antibiotics and IFD status accounted for 68%, 25%, 5% and 2%, respectively, compared with 85%, 11%, 2% and 2%, respectively, for no IFD (P<0.001). Among the allogeneic transplant patients, £36 914 (60%) of the total cost (£60 917) was used during the first 100 days.

CONCLUSIONS

IFD was associated with longer length of stay and higher total overall cost of care, with attributable costs greater than £50 000 per case of IFD. Costs for inpatient stay far outstrip the cost of antifungal agents.

摘要

目的

侵袭性真菌病(IFD)的直接成本包括抗真菌药物和诊断测试。本研究旨在确定这些成本。

方法

共纳入 203 例血液科患者,中位随访时间为 556 天。前瞻性收集抗真菌药物、诊断测试、住院时间和抗生素使用情况的数据。

结果

每位患者(使用英国参考成本)的总体平均(IQR)护理费用分别为确诊/疑似 IFD 为 £88911(45339-121594)、可能 IFD 为 £61509(39748-78383)、未分类为 IFD 为 £50332(23037-72057)和无 IFD 为 £34075(19928-43900)(P<0.001)。IFD 的归因成本为 £54836。住院治疗占总费用的近 74%。在确诊/疑似 IFD 患者中,住院治疗、抗真菌药物、抗生素和 IFD 状态分别占 68%、25%、5%和 2%,而无 IFD 患者分别占 85%、11%、2%和 2%(P<0.001)。在异基因移植患者中,总费用(£60917)的 £36914(60%)用于前 100 天。

结论

IFD 与住院时间延长和总体护理费用增加有关,归因成本每例 IFD 超过 £50000。住院费用远远超过抗真菌药物的成本。

相似文献

1
Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK.英国成人血液科患者队列中侵袭性真菌病诊断和治疗成本的前瞻性评估。
J Antimicrob Chemother. 2015 Apr;70(4):1175-81. doi: 10.1093/jac/dku506. Epub 2014 Dec 21.
2
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.血液系统恶性肿瘤伴高危发热性中性粒细胞减少患者经验性与抢先抗真菌策略的Meta分析及成本比较
PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015.
3
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.德国医院中急性髓系白血病(AML)或骨髓增生异常综合征(MDS)患者侵袭性真菌病(IFD)的治疗费用。
Mycoses. 2012 Nov;55(6):514-20. doi: 10.1111/j.1439-0507.2012.02193.x. Epub 2012 Apr 3.
4
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.中国造血干细胞移植患者侵袭性真菌病的流行病学、管理及结局:一项多中心前瞻性观察研究
Biol Blood Marrow Transplant. 2015 Jun;21(6):1117-26. doi: 10.1016/j.bbmt.2015.03.018. Epub 2015 Mar 31.
5
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.法国血液系统疾病或造血干细胞移植患者抗真菌治疗的适应证和结局。
J Antimicrob Chemother. 2012 Nov;67(11):2731-8. doi: 10.1093/jac/dks266. Epub 2012 Jul 31.
6
A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015.基于全州注册和成本数据库数据链接的血液恶性肿瘤患者侵袭性真菌感染病归因性住院费用的人群分析:2009-2015 年。
Mycoses. 2020 Feb;63(2):162-171. doi: 10.1111/myc.13033. Epub 2019 Dec 4.
7
Triggers for driving treatment of at-risk patients with invasive fungal disease.驱动高危侵袭性真菌病患者治疗的触发因素。
J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii17-iii24. doi: 10.1093/jac/dkt391.
8
Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.开发和验证一种风险模型,用于识别非中性粒细胞减少、危重症成年患者侵袭性念珠菌感染的高危人群:真菌感染风险评估(FIRE)研究。
Health Technol Assess. 2013 Feb;17(3):1-156. doi: 10.3310/hta17030.
9
Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.既往有侵袭性真菌病的血液系统恶性肿瘤患者的二线抗真菌预防:一项回顾性分析。
PLoS One. 2014 Dec 22;9(12):e115461. doi: 10.1371/journal.pone.0115461. eCollection 2014.
10
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.对于接受异基因干细胞移植的血液肿瘤高危患者,米卡芬净桥接治疗的成本与资源利用分析。
Eur J Haematol. 2015 Jun;94(6):526-31. doi: 10.1111/ejh.12466. Epub 2015 Feb 23.

引用本文的文献

1
Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom.英国高危免疫抑制患者疑似曲霉菌感染的诊断驱动和经验性治疗策略的真实世界财务和临床影响。
Microbiol Spectr. 2022 Jun 29;10(3):e0042522. doi: 10.1128/spectrum.00425-22. Epub 2022 May 9.
2
SUMOylation in Human Pathogenic Fungi: Role in Physiology and Virulence.人类致病真菌中的SUMO化修饰:在生理和毒力中的作用
J Fungi (Basel). 2020 Mar 4;6(1):32. doi: 10.3390/jof6010032.
3
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and spp.
鉴定与两性霉素 B 具有协同作用或对新型隐球菌和 spp.具有抗真菌作用的非专利药物
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01921-19.
4
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico.伏立康唑、氟康唑和两性霉素B用于墨西哥异基因造血干细胞移植后侵袭性真菌感染的成本效益分析
Clinicoecon Outcomes Res. 2018 Sep 6;10:511-520. doi: 10.2147/CEOR.S157642. eCollection 2018.
5
Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK.英国使用伊曲康唑治疗侵袭性霉菌病与两性霉素 B 脂质体相比的经济影响。
Future Microbiol. 2018 Sep;13(11):1283-1293. doi: 10.2217/fmb-2018-0119. Epub 2018 Jun 18.
6
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.血液系统恶性肿瘤伴高危发热性中性粒细胞减少患者经验性与抢先抗真菌策略的Meta分析及成本比较
PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015.